Skip to content
  • KOSPI 2788.82 -45.47 -1.60%
  • KOSDAQ 915.29 -27.56 -2.92%
  • KOSPI200 370.73 -5.35 -1.42%
  • USD/KRW 1193.6 3.20 0.27%
  • JPY100/KRW 1,049.36 5.20 0.50%
  • EUR/KRW 1,353.54 6.78 0.50%
  • CNH/KRW 188.04 0.39 0.21%
View Market Snapshot

Biotech firm EDGC embarks on metaverse journey 

The joint venture is also ISO-certified for information security and clinical data management

By Jan 05, 2022 (Gmt+09:00)

EONE-DIAGNOMICS Genome Center Co. ( EDGC ) announced this week it would participate in AI Human Metaverse Project consortium – along with seven other companies including VR developer MAXST Co. and online gaming platform KLASS SOFT.

The goal of the consortium will be creating a parallel universe that mirrors the physical world in the virtual space.

In the fourth generation social networking service, hundreds of millions of users should be able to perform socio-economic activities like watching videos and performances, playing games, and getting medical services. The users' avatars will engage in business transactions through these activities.

The laboratory of EONE-DIAGNOMICS Genome Center Co. in Korea
The laboratory of EONE-DIAGNOMICS Genome Center Co. in Korea


So what role does the genome analysis provider play on metaverse? 

The short answer is transplanting genetic information onto the digital universe. EDGC describes the new business model as “realizing the next generation value of genome big data.” 

The company will use YouWho, its platform technology based on genome big data, to allow users to attach relevant DNA characteristics to their avatars. 

In creating the platform, EDGC has been working with twelve companies around the world, such as San Diego-based Illumina, Inc., Broad Institute of Harvard University and MIT, and 23andMe, Inc.; participating in a genome standardization project since 2016. Approximately 10 million people took part in the project. 

“I am glad to witness the process of genome big data being inserted in the metaverse for the first time in the world,” said EDGC director Tae-hyun. “As the YouWho engine can be implemented in nearly all aspects of our lives, it will be another cash cow for the company.”

Lee Min-seob, CEO of EONE-DIAGNOMICS Genome Center Co.
Lee Min-seob, CEO of EONE-DIAGNOMICS Genome Center Co.


Last Wednesday, EDGC got certified for its information security management system (ISO 27001) and medical informatics security management (ISO 27799) in the the field of genome services.

ISO 27001 is the most powerful certification in the information security field for companies. To attain the seal of approval, the business needs to pass a review on 14 management areas and 114 sub-areas of information security. 

The more specialized ISO 27799 is for medical informatics security management for precision medicine. To achieve this, a company needs to abide by legitimate and safe management of the most sensitive and personal clinical data including medical charts, prescription records, examination results, and more. 

EDGC is so far the only genome service company that concurrently acquired two types of ISO certifications in Korea, according to the EDGC press release. Established in 2013, the company uses AI technologies such as deep learning and machine learning to guarantee high levels of security and transparency. 

Lee Sung-hoon, EDGC’s R&D division chief said, “The analysis, utilization, and management are the keys in the genome services sector.”

EDGC is an international joint venture established between EONE Laboratories and Diagnomics, developing technology for genome analysis.

Write to Ye-na Kim, Min-soo Han at

Jee Abbey Lee edited this article. 
Comment 0